Features

PIVOT Study Results Challenged

Researchers question the generalizability of a major study showing no significant difference in cancer-specific and overall survival between surgery and observation for localized prostate cancer.

Managing Lymph Node-Positive PCa

In patients with suspicious lymph node involvement at preoperative imaging, radiation therapy or radical prostatectomy with or without systemic therapies should be recommended as part ...

New Ways to Cut Prostate Biopsy Infection Risk

Alcohol needle washing and pre-biopsy rectal cultures for targeted prophylaxis are among the potentially beneficial strategies.

Extended Lymph Node Dissection for PCa

Study shows that the risk of recurrence after salvage radiotherapy is inversely related to the number of nodes resected at radical prostatectomy.

Management of Oligometastatic PCa

More and more cases of oligometastatic PCa are being diagnosed as a result of advances in molecular imaging, but clinical trial data about the best ...

Latest Prostate Cancer News

Prostate Cancer Diagnoses Increase Men's Suicide Risk

Prostate Cancer Diagnoses Increase Men's Suicide Risk

A patient's risk of suicide is doubled within the first year following a prostate cancer diagnosis, according to a new meta-analysis.

Obese Prostate Cancer Patients Do Worse After Radical Prostatectomy

Obese Prostate Cancer Patients Do Worse After Radical Prostatectomy

Study of Korean radical prostatectomy patients showed that those who were obese had significant increased odds of biochemical recurrence and cancer-specific mortality

Cytoreductive Surgery for Metastatic PCa Linked to More Complications

Cytoreductive Surgery for Metastatic PCa Linked to More Complications

Cytoreductive radical prostatectomy (RP) for metastatic prostate cancer (PCa) is associated with higher complication rates and longer hospital stays than RP for non-metastatic PCa.

Persistent Cancer Screening Gaps Revealed in New CDC Report

Persistent Cancer Screening Gaps Revealed in New CDC Report

From 2000 to 2015 screening for breast, cervical, and prostate cancers decreased significantly, whereas screening for colorectal cancer increased significantly.

Use of Post-RP High Dose Radiotherapy Increasing

Use of Post-RP High Dose Radiotherapy Increasing

Physicians increasingly are prescribing high dose and very high dose radiation therapy after radical prostatectomy despite an absence of randomized trials supporting the practice.

First-Line Enzalutamide May Confer a Survival Benefit for mCRPC

First-Line Enzalutamide May Confer a Survival Benefit for mCRPC

Patients may benefit from earlier lines of enzalutamide for the treatment of metastatic castration-resistant prostate cancer.

SBRT Appears Effective for Oligometastatic Prostate Cancer

SBRT Appears Effective for Oligometastatic Prostate Cancer

Stereotactic body radiation therapy achieves good local control of metastases in patients with recurrent prostate cancer following primary treatment.

Prostate Cancer Brachytherapy Outcomes Linked to PSADT

Prostate Cancer Brachytherapy Outcomes Linked to PSADT

Shorter PSA double times are associated with worse disease-specific, metastasis-free, and overall survival, study finds.

Prostate Cancer Outcomes Improve With Tailored Post-RP Treatment

Prostate Cancer Outcomes Improve With Tailored Post-RP Treatment

Radiation therapy dose escalation, pelvic lymph node irradiation, and hormone therapy duration are prescribed based on patient and tumor characteristics.

Prostate Cancer Risk Reduced in Men with Very Low Free Testosterone

Prostate Cancer Risk Reduced in Men with Very Low Free Testosterone

Men in the bottom 10th of free testosterone level vs those with higher levels were found to have a 23% decreased risk of prostate cancer.

Study Supports Prostate Cancer Active Surveillance for Younger Men

Study Supports Prostate Cancer Active Surveillance for Younger Men

Younger men with prostate cancer are less likely to experience Gleason score upgrading and pathologic progression on repeat biopsy.

Salvage RARP Feasible, Effective

Salvage RARP Feasible, Effective

According to researchers, 57.3% of men who underwent salvage robot-assisted radical prostatectomy were pad-free at 12 months.

Shorter ADT Course May Suffice for High-Risk Prostate Cancer

Shorter ADT Course May Suffice for High-Risk Prostate Cancer

New study shows no significant difference in overall survival between 18 and 36 months of androgen deprivation therapy used in combination with radiation therapy.

Aggressive Therapy Warranted for Gleason 10 Prostate Cancer

Aggressive Therapy Warranted for Gleason 10 Prostate Cancer

Regardless of treatment modality, men with Gleason 10 prostate cancer have high 5-year overall survival rates, new study finds.

PET/CT May Improve Imaging of Recurrent Prostate Cancer

PET/CT May Improve Imaging of Recurrent Prostate Cancer

Early study results are encouraging, but high-quality data that validate PET/CT against a reliable reference standard are lacking.

Sign up for free e-Newsletters